Covid-19 (Temas de Saúde Pública)
Por que a subvariante Ômicron se dissemina mais rápido que a original?
22 Fev, 2022 | 15:35hWhy does the Omicron sub-variant spread faster than the original? – Nature
Conteúdos relacionados:
Covid-19: What do we know about omicron sublineages?
We regret to inform you that we are now discussing subvariants – Vox
Sudden rise of more transmissible form of Omicron catches scientists by surprise.
Omicron’s sister variant spreads faster. So why did the one we call Omicron hit first?
BA.2 is like Omicron’s sister. Here’s what we know about it so far – The Conversation
Revisão da literatura e metanálise | Efetividade das vacinas contra COVID-19 no mundo real.
22 Fev, 2022 | 14:53hPerspectiva | É hora de conviver com a COVID-19? Alguns cientistas alertam para uma “ilusão endêmica”.
22 Fev, 2022 | 14:48hIs it time to live with COVID-19? Some scientists warn of ‘endemic delusion’ – Science
Estudo de coorte | Riscos de desfechos de saúde mental em pessoas com Covid-19.
19 Fev, 2022 | 14:08hRisks of mental health outcomes in people with covid-19: cohort study – The BMJ
Editorial: Mental health after covid-19 – The BMJ
Comunicado de imprensa: Study suggests increased risk of mental health disorders after COVID-19 infection – BMJ
Comentários:
Mental health in people with covid-19 – The BMJ
Large study reveals clearer links between COVID-19, mental health risks – CIDRAP
Outro estudo sugere que há um risco menor de internação e morte na infecção pela variante Ômicron do SARS-CoV-2 vs. a variante Delta.
19 Fev, 2022 | 14:06hEstimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada – JAMA
Diretriz provisória da OMS | Rastreamento de contatos e quarentena no contexto da variante Ômicron do SARS-CoV-2.
19 Fev, 2022 | 14:04h
Comentário no Twitter (fio – clique para saber mais)
#COVID19 quarantine period may be shortened for contacts who test negative on a PCR or antigen based rapid diagnostic test. Quarantine can be shortened, for example to seven days, if the contact shows no symptoms & presents a negative test https://t.co/ERF0HDcJOU https://t.co/TsbcHw86B7
— World Health Organization (WHO) (@WHO) February 17, 2022
Opinião | Os coronavírus são “espertos”: cenários evolutivos para o futuro do SARS-CoV-2.
19 Fev, 2022 | 14:01hCoronaviruses are ‘clever’: Evolutionary scenarios for the future of SARS-CoV-2 – STAT
Perspectiva | Estamos entrando na fase de controle da pandemia.
19 Fev, 2022 | 13:59hWe’re Entering the Control Phase of the Pandemic – The Atlantic
Estudo randomizado | Nirmatrelvir oral para adultos de alto risco com Covid-19 reduz em 89% o risco de internação.
17 Fev, 2022 | 15:37hEntrevista em áudio: A New Antiviral against Covid-19 – new England Journal of Medicine
Conteúdos relacionados:
Comentário no Twitter
The Paxlovid pill (Nirmatrelvir) randomized, placebo-controlled trial published @NEJM:
89% efficacy vs Covid hospitalizations or deaths, and quick reduction of viral load.
The active pills had less serious adverse events or discontinuations than placebohttps://t.co/HBMRZt4wBo pic.twitter.com/LDQv41O56c— Eric Topol (@EricTopol) February 16, 2022
Estudo de coorte retrospectiva | Vacina da Pfizer reduz o risco de reinfecção após recuperação da Covid-19.
17 Fev, 2022 | 15:35hEffectiveness of the BNT162b2 Vaccine after Recovery from Covid-19 – New England Journal of Medicine
Comentário no Twitter
Among patients who had recovered from Covid-19, the receipt of at least one dose of the BNT162b2 vaccine was associated with a significantly lower risk of recurrent infection. https://t.co/AAlsY9sFlv pic.twitter.com/Nkj1lP77ZW
— NEJM (@NEJM) February 16, 2022